首页> 美国卫生研究院文献>Molecular Pain >RNA interference-based functional knockdown of the voltage-gated potassium channel Kv7.2 in dorsal root ganglion neurons after in vitro and in vivo gene transfer by adeno-associated virus vectors
【2h】

RNA interference-based functional knockdown of the voltage-gated potassium channel Kv7.2 in dorsal root ganglion neurons after in vitro and in vivo gene transfer by adeno-associated virus vectors

机译:腺相关病毒载体体外和体内基因转移后基于RNA干扰的背根神经节神经元中电压门控钾通道Kv7.2的功能性敲低

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Activation of the neuronal potassium channel Kv7.2 encoded by the KCNQ2 gene has recently been shown to be an attractive mechanism to inhibit nociceptive transmission. However, potent, selective, and clinically proven activators of Kv7.2/Kv7.3 currents with analgesic properties are still lacking. An important prerequisite for the development of new drugs is a model to test the selectivity of novel agonists by abrogating Kv7.2/Kv7.3 function. Since constitutive knockout mice are not viable, we developed a model based on RNA interference-mediated silencing of KCNQ2. By delivery of a KCNQ2-specific short hairpin RNA with adeno-associated virus vectors, we completely abolished the activity of the specific Kv7.2/Kv7.3-opener ICA-27243 in rat sensory neurons. Results obtained in the silencing experiments were consistent between freshly prepared and cryopreserved dorsal root ganglion neurons, as well as in dorsal root ganglion neurons dissociated and cultured after in vivo administration of the silencing vector by intrathecal injections into rats. Interestingly, the tested associated virus serotypes substantially differed with respect to their transduction capability in cultured neuronal cell lines and primary dorsal root ganglion neurons and the in vivo transfer of transgenes by intrathecal injection of associated virus vectors. However, our study provides the proof-of-concept that RNA interference-mediated silencing of KCNQ2 is a suitable approach to create an ex vivo model for testing the specificity of novel Kv7.2/Kv7.3 agonists.
机译:最近显示,由KCNQ2基因编码的神经元钾通道Kv7.2的激活是抑制伤害性传递的诱人机制。但是,仍然缺乏具有止痛特性的有效,选择性和临床证明的Kv7.2 / Kv7.3电流激活剂。开发新药的重要先决条件是通过废除Kv7.2 / Kv7.3功能来测试新型激动剂选择性的模型。由于本构型敲除小鼠不可行,我们开发了基于RNA干扰介导的KCNQ2沉默的模型。通过与腺相关病毒载体一起递送KCNQ2特异性短发夹RNA,我们完全消除了大鼠感觉神经元中特定Kv7.2 / Kv7.3-opener ICA-27243的活性。在沉默实验中获得的结果在新鲜制备的和冷冻保存的背根神经节神经元之间,以及通过鞘内注射向大鼠体内施用沉默载体后解离和培养的背根神经节神经元中是一致的。有趣的是,所测试的相关病毒血清型在其在培养的神经元细胞系和初级背根神经节神经元中的转导能力以及通过鞘内注射相关病毒载体进行的转基因体内转移方面存在显着差异。但是,我们的研究提供了概念证明,即RNA干扰介导的KCNQ2沉默是创建体外模型以测试新型Kv7.2 / Kv7.3激动剂特异性的合适方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号